← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #730 OF 1,000 MOST-CITED

Person performing, test results, interpretation

FDA cited this observation 22 times across 22 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Biologics22
BY FISCAL YEAR
FY20263
FY20254
FY20245
FY20232
FY20221
FY20195
FY20182

How FDA worded it — real examples

Records fail to identify the person performing the work so as to provide a complete history of the work performed.

North Shore University Hospital Northwell Health · Manhasset, New York · Biologics · 2026-03-11

Records fail to show test results so as to provide a complete history of the work performed.

Biomat USA Inc · Surprise, Arizona · Biologics · 2026-02-04

Records fail to identify the person performing the work and be as detailed as necessary so as to provide a complete history of the work performed.

New York Blood Center Enterprises · Melville, New York · Biologics · 2025-12-05

Records fail to identify the person performing the work, include dates of the various entries and be as detailed as necessary so as to provide a complete history of the work performed.

Pasadena Hospital Association, Ltd. · Pasadena, California · Biologics · 2025-09-12

Records fail to identify the person performing the work, include dates of the various entries and be as detailed as necessary so as to provide a complete history of the work performed.

Rhode Island Blood Center, A Division of New York Blood Center, Inc. · Providence, Rhode Island · Biologics · 2025-08-01

Records fail to be as detailed as necessary so as to provide a complete history of the work performed.

Department of Defense - Navy (U.S. Naval Hospital Naples) · Naples · Biologics · 2025-04-15

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Biologics industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →